Learning Objectives:
1. Describe the incidence of and when to suspect VITT
2. Review the available evidence linking COVID-19 vaccines to thrombosis with thrombocytopenia syndrome
3. Discuss work up and management of suspected or confirmed VITT
Session date:
06/10/2021 - 8:00am to 9:00am CDT
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Dario Villamar, MD